Cargando…

The importance of biomarker development for monitoring type 1 diabetes progression rate and therapeutic responsiveness

Type 1 diabetes (T1D) is an autoimmune condition of children and adults in which immune cells target insulin-producing pancreatic β-cells for destruction. This results in a chronic inability to regulate blood glucose levels. The natural history of T1D is well-characterized in childhood. Evidence of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fyvie, Maxwell J., Gillespie, Kathleen M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225507/ https://www.ncbi.nlm.nih.gov/pubmed/37256143 http://dx.doi.org/10.3389/fimmu.2023.1158278

Ejemplares similares

Neoepitopes in Type 1 Diabetes: Etiological Insights, Biomarkers and Therapeutic Targets
por: Rodriguez-Calvo, Teresa, et al.
Publicado: (2021)

Candidate Biomarkers for the Prediction and Monitoring of Partial Remission in Pediatric Type 1 Diabetes
por: Gomez-Muñoz, Laia, et al.
Publicado: (2022)

Biomarkers in Islet Cell Transplantation for Type 1 Diabetes
por: AlRashidi, Fatimah T., et al.
Publicado: (2018)

Evaluation of plasma IL-21 as a potential biomarker for type 1 diabetes progression
por: Schroderus, Anna-Mari, et al.
Publicado: (2023)

MDSCs in breast cancer: an important enabler of tumor progression and an emerging therapeutic target
por: Liu, Haoyu, et al.
Publicado: (2023)

Monitoring islet specific immune responses in type 1 diabetes clinical immunotherapy trials
por: Arif, Sefina, et al.
Publicado: (2023)

Monitoring immunomodulation strategies in type 1 diabetes
por: Krishnamurthy, Balasubramanian, et al.
Publicado: (2023)

Vitiligo Skin Biomarkers Associated With Favorable Therapeutic Response
por: Yang, Qianli, et al.
Publicado: (2021)

Current and Future Approaches for Monitoring Responses to Anti-complement Therapeutics
por: Mohebnasab, Maedeh, et al.
Publicado: (2019)

The Importance of the CXCL12/CXCR4 Axis in Therapeutic Approaches to Diabetes Mellitus Attenuation
por: Vidaković, Melita, et al.
Publicado: (2015)

Editorial: The importance of Th17/Treg imbalance in asthma and COPD development and progression
por: Lopes, Fernanda Degobbi T. Q. S., et al.
Publicado: (2022)

Monitoring Immune Responses in IgA Nephropathy: Biomarkers to Guide Management
por: Selvaskandan, Haresh, et al.
Publicado: (2020)

Investigating iron intake in risk of progression from islet autoimmunity to type 1 diabetes: The diabetes autoimmunity study in the young
por: Elhassan, Sulafa, et al.
Publicado: (2023)

Acute Versus Progressive Onset of Diabetes in NOD Mice: Potential Implications for Therapeutic Interventions in Type 1 Diabetes
por: Mathews, Clayton E., et al.
Publicado: (2015)

Microenvironmental Regulation of Tumor Progression and Therapeutic Response in Brain Metastasis
por: Schulz, Michael, et al.
Publicado: (2019)

Rising Incidence of Type 1 Diabetes Is Associated With Altered Immunophenotype at Diagnosis
por: Long, Anna E., et al.
Publicado: (2012)

Extracellular Vesicles in Immune System Regulation and Type 1 Diabetes: Cell-to-Cell Communication Mediators, Disease Biomarkers, and Promising Therapeutic Tools
por: Grieco, Giuseppina Emanuela, et al.
Publicado: (2021)

The AHR Signaling Attenuates Autoimmune Responses During the Development of Type 1 Diabetes
por: Yue, Tiantian, et al.
Publicado: (2020)

Using the T Cell Receptor as a Biomarker in Type 1 Diabetes
por: Nakayama, Maki, et al.
Publicado: (2021)

Adipokines as potential biomarkers for type 2 diabetes mellitus in cats
por: Sierawska, Olga, et al.
Publicado: (2022)

Biomarkers of autoimmunity and beta cell metabolism in type 1 diabetes
por: Yang, Mei-Ling, et al.
Publicado: (2022)

The need and benefit of immune monitoring to define patient and disease heterogeneity, mechanisms of therapeutic action and efficacy of intervention therapy for precision medicine in type 1 diabetes
por: Roep, Bart O.
Publicado: (2023)

Identification of biomarkers in patients with rheumatoid arthritis responsive to DMARDs but with progressive bone erosion
por: Marasco, Emiliano, et al.
Publicado: (2023)

The Evolving Landscape of Biomarkers in Celiac Disease: Leading the Way to Clinical Development
por: Smithson, Glennda, et al.
Publicado: (2021)

Lipid metabolism in type 1 diabetes mellitus: Pathogenetic and therapeutic implications
por: Zhang, Jing, et al.
Publicado: (2022)

Immune responses in diabetic nephropathy: Pathogenic mechanisms and therapeutic target
por: Chen, Jiahao, et al.
Publicado: (2022)

Cholinergic System and Its Therapeutic Importance in Inflammation and Autoimmunity
por: Halder, Namrita, et al.
Publicado: (2021)

Confirmation and Identification of Biomarkers Implicating Environmental Triggers in the Pathogenesis of Type 1 Diabetes
por: Harms, Robert Z., et al.
Publicado: (2020)

The role of inflammatory biomarkers in the development and progression of pre-eclampsia: a systematic review and meta-analysis
por: Guan, Xiaohan, et al.
Publicado: (2023)

Viral Evasion of the Complement System and Its Importance for Vaccines and Therapeutics
por: Mellors, Jack, et al.
Publicado: (2020)

Progress in the study of biomarkers for early prediction of systemic inflammatory response syndrome after percutaneous nephrolithotomy
por: Wu, Wangjian, et al.
Publicado: (2023)

Diverse Effects of Exosomes on COVID-19: A Perspective of Progress From Transmission to Therapeutic Developments
por: Gurunathan, Sangiliyandi, et al.
Publicado: (2021)

The Contribution of Neutrophils and NETs to the Development of Type 1 Diabetes
por: Petrelli, Alessandra, et al.
Publicado: (2022)

Bioactive Lipids as Chronic Myeloid Leukemia’s Potential Biomarkers for Disease Progression and Response to Tyrosine Kinase Inhibitors
por: de Almeida, Felipe Campos, et al.
Publicado: (2022)

Dysregulated Toll-Like Receptor–Induced Interleukin-1β and Interleukin-6 Responses in Subjects at Risk for the Development of Type 1 Diabetes
por: Alkanani, Aimon K., et al.
Publicado: (2012)

The Importance of Mouse Models to Define Immunovirologic Determinants of Progressive Multifocal Leukoencephalopathy
por: Frost, Elizabeth L., et al.
Publicado: (2015)

Important functional role of the protein osteopontin in the progression of malignant pleural mesothelioma
por: Digifico, Elisabeth, et al.
Publicado: (2023)

Association of Glomerular Complement C4c Deposition With the Progression of Diabetic Kidney Disease in Patients With Type 2 Diabetes
por: Duan, Suyan, et al.
Publicado: (2020)

Elevated Biomarkers of NETosis in the Serum of Pediatric Patients With Type 1 Diabetes and Their First-Degree Relatives
por: Klocperk, Adam, et al.
Publicado: (2021)

Type-I Interferons Inhibit Interleukin-10 Signaling and Favor Type 1 Diabetes Development in Nonobese Diabetic Mice
por: Iglesias, Marcos, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hs699pmf23ffpfu3f7g3jjk3nh